Vanguard Group’s Pacific Biosciences PACB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$19.9M Sell
16,017,175
-246,289
-2% -$305K ﹤0.01% 2560
2025
Q1
$19.2M Buy
16,263,464
+1,036,606
+7% +$1.22M ﹤0.01% 2519
2024
Q4
$27.9M Sell
15,226,858
-2,415,946
-14% -$4.42M ﹤0.01% 2422
2024
Q3
$30M Sell
17,642,804
-8,356,139
-32% -$14.2M ﹤0.01% 2401
2024
Q2
$35.6M Sell
25,998,943
-607,542
-2% -$832K ﹤0.01% 2285
2024
Q1
$99.8M Sell
26,606,485
-183,067
-0.7% -$687K ﹤0.01% 1869
2023
Q4
$263M Buy
26,789,552
+3,514,792
+15% +$34.5M 0.01% 1351
2023
Q3
$194M Buy
23,274,760
+147,993
+0.6% +$1.24M ﹤0.01% 1446
2023
Q2
$308M Buy
23,126,767
+851,077
+4% +$11.3M 0.01% 1229
2023
Q1
$258M Buy
22,275,690
+1,996,655
+10% +$23.1M 0.01% 1317
2022
Q4
$166M Buy
20,279,035
+616,969
+3% +$5.05M ﹤0.01% 1533
2022
Q3
$114M Sell
19,662,066
-1,579,252
-7% -$9.17M ﹤0.01% 1709
2022
Q2
$93.9M Buy
21,241,318
+1,296,226
+6% +$5.73M ﹤0.01% 1863
2022
Q1
$181M Buy
19,945,092
+90,216
+0.5% +$821K ﹤0.01% 1615
2021
Q4
$406M Buy
19,854,876
+1,858,227
+10% +$38M 0.01% 1136
2021
Q3
$460M Sell
17,996,649
-200,255
-1% -$5.12M 0.01% 1022
2021
Q2
$636M Buy
18,196,904
+430,821
+2% +$15.1M 0.02% 841
2021
Q1
$592M Buy
17,766,083
+3,445,784
+24% +$115M 0.02% 855
2020
Q4
$371M Buy
14,320,299
+3,950,323
+38% +$102M 0.01% 1057
2020
Q3
$102M Buy
10,369,976
+2,391,500
+30% +$23.6M ﹤0.01% 1678
2020
Q2
$27.5M Buy
7,978,476
+511,325
+7% +$1.76M ﹤0.01% 2277
2020
Q1
$22.8M Sell
7,467,151
-409,334
-5% -$1.25M ﹤0.01% 2223
2019
Q4
$40.5M Buy
7,876,485
+75,461
+1% +$388K ﹤0.01% 2212
2019
Q3
$40.3M Buy
7,801,024
+134,495
+2% +$694K ﹤0.01% 2177
2019
Q2
$46.4M Buy
7,666,529
+55,322
+0.7% +$335K ﹤0.01% 2138
2019
Q1
$55M Buy
7,611,207
+154,082
+2% +$1.11M ﹤0.01% 2039
2018
Q4
$55.2M Buy
7,457,125
+1,145,279
+18% +$8.47M ﹤0.01% 1981
2018
Q3
$34.1M Buy
6,311,846
+377,272
+6% +$2.04M ﹤0.01% 2317
2018
Q2
$21.1M Buy
5,934,574
+724,706
+14% +$2.57M ﹤0.01% 2541
2018
Q1
$10.7M Buy
5,209,868
+328,547
+7% +$673K ﹤0.01% 2798
2017
Q4
$12.9M Buy
4,881,321
+351,297
+8% +$927K ﹤0.01% 2702
2017
Q3
$23.8M Buy
4,530,024
+600,724
+15% +$3.15M ﹤0.01% 2409
2017
Q2
$14M Buy
3,929,300
+283,216
+8% +$1.01M ﹤0.01% 2614
2017
Q1
$18.9M Buy
3,646,084
+424,632
+13% +$2.2M ﹤0.01% 2466
2016
Q4
$12.2M Buy
3,221,452
+73,304
+2% +$279K ﹤0.01% 2654
2016
Q3
$28.2M Buy
3,148,148
+225,702
+8% +$2.02M ﹤0.01% 2206
2016
Q2
$20.6M Buy
2,922,446
+388,950
+15% +$2.74M ﹤0.01% 2324
2016
Q1
$21.5M Buy
2,533,496
+205,899
+9% +$1.75M ﹤0.01% 2273
2015
Q4
$30.6M Buy
2,327,597
+287,529
+14% +$3.78M ﹤0.01% 2121
2015
Q3
$7.47M Buy
2,040,068
+125,397
+7% +$459K ﹤0.01% 2767
2015
Q2
$11M Buy
1,914,671
+97,013
+5% +$559K ﹤0.01% 2623
2015
Q1
$10.6M Buy
1,817,658
+190,484
+12% +$1.11M ﹤0.01% 2622
2014
Q4
$12.8M Buy
1,627,174
+123,983
+8% +$972K ﹤0.01% 2433
2014
Q3
$7.38M Buy
1,503,191
+46,758
+3% +$230K ﹤0.01% 2637
2014
Q2
$9M Buy
1,456,433
+101,567
+7% +$628K ﹤0.01% 2553
2014
Q1
$7.25M Buy
1,354,866
+352,481
+35% +$1.89M ﹤0.01% 2640
2013
Q4
$5.24M Buy
1,002,385
+213,476
+27% +$1.12M ﹤0.01% 2781
2013
Q3
$4.36M Buy
788,909
+166,198
+27% +$919K ﹤0.01% 2810
2013
Q2
$1.57M Buy
+622,711
New +$1.57M ﹤0.01% 3152